This inventor holds 3 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1992-1998.
Company Filing History:
Years Active: 1992-1998
Title: Gudrun Bertram: Innovator in Progesterone Synthesis Inhibitors
Introduction
Gudrun Bertram is a notable inventor based in Jena, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that impact progesterone synthesis. Her work has implications for various medical conditions, including endometriosis and hormone-dependent tumors.
Latest Patents
Gudrun Bertram holds 3 patents related to her innovative work. Her latest patents include the invention of 11 Beta-aryl-gona-4,9-dien-3-ones. This invention pertains to compounds that act as progesterone synthesis inhibitors, which are suitable for inducing labor or an abortion, as well as for treating endometriosis, dysmenorrhea, and endocrine hormone-dependent tumors. Another patent focuses on 11.beta.-aryl-gona-4,9-dien-3-ones, which are progesterone antagonists also suitable for similar medical applications.
Career Highlights
Gudrun Bertram has established herself as a key figure in her field through her innovative research and development efforts. Her work at Schering Aktiengesellschaft has allowed her to explore and develop new therapeutic options that address critical health issues.
Collaborations
Throughout her career, Gudrun has collaborated with esteemed colleagues, including Helmut Kasch and Kurt Ponsold. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Gudrun Bertram's contributions to the field of medicinal chemistry are significant, particularly in the development of progesterone synthesis inhibitors. Her innovative patents and collaborative efforts continue to impact medical science positively.